A systematic review and meta-analysis of the efficacy and safety of mirabegron vs. tamsulosin in alleviating double-J catheter related symptoms.

ABSTRACT:

Background

Currently, many clinicians use tamsulosin as a medication to alleviate symptoms following double J (DJ) stent insertion. With the emerging advantages of β-receptor agonists in relieving urinary tract spasms, the effectiveness of mirabegron in treating DJ stent-related symptoms has gained attention.

Objective

To explore which medication, mirabegron or tamsulosin, is more effective in alleviating DJ stent-related symptoms.

Methods

A literature search was conducted to identify randomized controlled trials (RCTs) that evaluated the use of mirabegron and tamsulosin in relieving DJ stent-related symptoms. Databases searched included PubMed, Web of Science, Cochrane Library, Embase, and CNKI, with the search cutoff date in June 2024. Inclusion criteria were

SUBMITTER: Zhang J 

PROVIDER: S-EPMC12621141 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature